Technology Offerings

Innovative Combo Therapy Targeting Pancreatic and Colon Cancer

The current invention is based on combination therapies of nucleoside analogs with inhibitors of either the Nodal/Activin pathway or the mTOR / hedgehog pathway and show a remarkable capacity to eliminate cancer stem cells

and to subsequently inhibit pancreatic and/or colon cancer.

Further Information: PDF

Bayerische Patentallianz GmbH
Phone: +49 89 5480177-0

Contact
Peer Biskup

Comments (0)

Write a comment